Since p16 is a critical regulator of CDK4/6-RB signaling preventing G1/S cell cycle progression (43, 44), p16 deletion/functional loss likely cooperates with the CRTC1-MAML2 fusion in tumor progression. Here, CDKN2A is linked to neoplasm.